The entire landscape of hospital-based clinical trials dramatically changed when COVID-19 singlehandedly stopped the global recruitment of ongoing cardiovascular trials. Heart failure clinical trials were already subject to factors such as regional variation in clinical practice, trial implementation, and patient characteristics, which drive event rate and treatment effect size assumptions key to demonstrating clinical benefit. Learn how CCS and SCIRENT applied agile cardiovascular trial management practices to handle this crisis.
Dr. Marvin Konstam (CCS), Patrica Wedge (CCS), and Elvis Tahirovic (SCIRENT) will explore the best practices Cardiovascular Clinical Sciences (CCS) and SCIRENT employed to navigate the pandemic landscape to reactivate global heart failure clinical trials rapidly and safely for successful recruitment of ongoing studies.
Agenda
About SCIRENT
SCIRENT is a full-service contract research organization (CRO) specialized in cardiovascular trial services. Our services cover the whole range of clinical trial services. Our CRO was founded in 2012 with the vision to help clients develop innovative medical drugs and devices for patients with cardiovascular diseases. Our dedicated team of experienced clinical and regulatory professionals can provide faster and more efficient service from our trial sites in Europe and beyond.
About CCS Trials
CCS was founded in 1997 by two cardiologists with a single vision: better clinical trial management through more effective integration of thought leader, site, and patient perspectives. For over three decades CCS has led groundbreaking cardiovascular research from single-center phase I studies to 10,000 patient pivotal trials, navigating complexity with ease.
SCIRENT, a full-service contract research organization (CRO) specializing in cardiovascular trials, is joining forces with CCS, a US-based cardiovascular clinical research organization, at HFSA Annual Scientific
10.08.2022. SCIRENT is excited to participate at the ESC Congress 2022 in Barcelona, which is taking place from 26-29 August 2022. Please book an appointment
10.11.2021. SCIRENT is attending the American Heart Association’s Scientific Sessions, AHA 2021, from November 13-15, 2021 as a proud exhibitor. Visit our booth and connect
BERLIN, Sept. 21, 2021 /PRNewswire/ — SCIRENT, an international full-service cardiovascular contract research organization (CRO), is proud to appoint Dr. Maximilian Posch as Chief Medical
Berlin Heals’ innovative implantable C-MIC device delivers encouraging clinical results in the treatment of heart failure.
The entire landscape of hospital-based clinical trials dramatically changed when COVID-19 singlehandedly stopped the global recruitment of ongoing cardiovascular trials. Heart failure clinical trials were
